Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea (VABAD)

NCT03059537 PHASE4 COMPLETED

This study aims to validate a possible diagnostic test for bile acid diarrhoea prospectively compared to the SeHCAT scintigraphy. Fasting participants are given a standard meal and 1,250 mg chenodeoxycholic acid. The investigators measure fasting FGF19, bile acids species including 7-alpha-CHO and serial blood samples after the stimulation.

Details

Lead sponsor	Lars Kristian Munck
Phase	PHASE4
Status	COMPLETED
Enrolment	71
Start date	Mon Mar 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Nov 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Bile Acid Malabsorption

Interventions

• Oral chenodeoxycholic acid stimulation

Countries

Denmark